SCHEMBL4495

SCHEMBL4495

C1CC2C[C]2CN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15751669 0.76
SCHEMBL18763434 0.76
SCHEMBL3234419 0.71
SCHEMBL11605 0.71
SCHEMBL18763492 0.70 HRH4 (0.36)
SCHEMBL28165752 0.65 SLC18A3 (0.35)
SCHEMBL6788944 0.65
SCHEMBL20521142 0.65
SCHEMBL18763487 0.65
SCHEMBL3764762 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 6231 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024131776-A1 BUFALIN DERIVATIVE AND PREPARATION METHOD THEREFOR, COMPOSITION, PREPARATION, AND APPLICATION 上海邈基生物科技有限公司 2024-06-27 WO claimed
WO-2023225244-A1 HETEROCYCLIC COMPOUNDS FOR TREATING HUNTINGTON'S DISEASE BIOGEN MA INC. (US) 2023-11-23 WO claimed
US-20230096517-A1 GLUTARIMIDE SKELETON-BASED COMPOUNDS AND APPLICATION THEREOF SHANGHAITECH UNIVERSITY (CN) 2023-03-30 US claimed
EP-4112614-A1 GLUTARIMIDE SKELETON-BASED COMPOUNDS AND APPLICATION THEREOF Shanghaitech University (CN) 2023-01-04 EP claimed
WO-2022266458-A1 6-HETEROCYCLOALKYL-QUINAZOLINE DERIVATIVES AND USES THEREOF BLACK DIAMOND THERAPEUTICS, INC. (US) 2022-12-22 WO claimed
US-20220143002-A1 SULFUR-CONTAINING COMPOUND BASED ON GLUTARIMIDE SKELETON AND APPLICATION THEREOF SHANGHAITECH UNIVERSITY (CN) 2022-05-12 US claimed
EP-3932922-A1 SULFUR-CONTAINING COMPOUND BASED ON GLUTARIMIDE SKELETON AND APPLICATION THEREOF ShanghaiTech University (CN) 2022-01-05 EP claimed
US-20210171467-A1 REDOX SUBSTRATES FOR LEUKOCYTE ESTERASE THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2021-06-10 US claimed
EP-3310784-B1 TRICYCLIC COMPOUNDS AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS. PFIZER (US) 2020-10-07 EP claimed
US-10669279-B2 Imidazopyridazine compounds PFIZER INC. (US) 2020-06-02 US claimed
EP-1594858-A2 NOVEL BENZOIMIDAZOLE DERIVATIVES USEFUL AS ANTIPROLIFERATIVE AGENTS Pfizer Products Inc. (US) 2005-11-16 EP claimed
US-20050176720-A1 Pharmaceutical composition for the treatment of CNS and other disorders PFIZER INC 2005-08-11 US claimed
EP-1150973-B1 HETEROARYL-SUBSTITUTED QUINOLIN-2-ONE DERIVATIVES USEFUL AS ANTICANCER AGENTS PFIZER PROD INC (US) 2005-06-15 EP claimed
US-20050124599-A1 Novel benzoimidazole derivatives useful as antiproliferative agents PFIZER INC. 2005-06-09 US claimed
US-6881734-B2 Pharmaceutical composition for the treatment of CNS and other disorders PFIZER INC. (US) 2005-04-19 US claimed
US-20050020625-A1 Processes for the preparation of benzoimidazole derivatives PFIZER INC 2005-01-27 US claimed
WO-2004113322-A1 PROCESSES FOR THE PREPARATION OF 1-[(BENZOIMIDAZOLE-1YL) QUINOLIN-8-YL] PIPERIDIN-4-YLAMINE DERIVATIVES PFIZER PRODUCTS INC. (US) 2004-12-29 WO claimed
US-6809094-B2 N-FUSED HETERCYCLO-1,4- OR -1,5- DIAZABICYCLO DERIVATIVES; NICOTINIC RECEPTOR AGONISTS; CENTRAL NERVOUS SYSTEM (CNS) PFIZER INC 2004-10-26 US claimed
US-20040204416-A1 Pharmaceutical composition for the treatment of CNS and other disorders PFIZER INC 2004-10-14 US claimed
WO-2004020431-A2 NOVEL BENZOIMIDAZOLE DERIVATIVES USEFUL AS ANTIPROLIFERATIVE AGENTS PFIZER PRODUCTS INC. (US) 2004-03-11 WO claimed